Downregulation of Na(+)–NQR complex is essential for Vibrio alginolyticus in resistance to Balofloxacin (cas 127294-70-6)

Add time:08/09/2019    Source:sciencedirect.com

Increasingly isolated frequency of antibiotic-resistant V. alginolyticus strains in clinic and aquaculture has been reported, but the mechanisms of V. alginolyticus antibiotic resistance are largely absent. In the present study, native/SDS-PAGE based proteomics, which may provide information on protein–protein interaction, was utilized to investigate differential proteins of V. alginolyticus in resistance to balofloxacin. Ten proteins were altered, in which V12G01_04671, V12G01_00457, V12G01_15927, V12G01_15240, NqrA (spot 26), and NqrF (spot 30) were downregulated, while V12G01_22043, TolC, V12G01_15130, V12G01_19297 were upregulated. Importantly, the two components of Na(+)–NQR complex, NqrA and NqrF, were vertically lined and was further investigated. Western blotting assay indicated that downregulation of the two proteins contrasted sharply with upregulation of a control protein TolC, which was consistent with the result obtained from 2-DE gel analysis. Furthermore, overexpression of NqrA, NqrF and TolC resulted in decrease and elevation of bacterial survival ability in medium with balofloxacin, respectively. These results indicate that downregulation of Na(+)–NQR complex is essential for V. alginolyticus resistance to balofloxacin. This is the first report on the role of Na(+)–NQR complex in antibiotic resistance. This finding highlights the way to an understanding of antibiotic-resistant mechanisms in content of metabolic regulation.

We also recommend Trading Suppliers and Manufacturers of Balofloxacin (cas 127294-70-6). Pls Click Website Link as below: cas 127294-70-6 suppliers

Prev:Exploring the aquatic photodegradation of two ionisable fluoroquinolone antibiotics – Gatifloxacin and Balofloxacin (cas 127294-70-6): Degradation kinetics, photobyproducts and risk to the aquatic environment
Next:Synthesis and in vitro antimycobacterial activity of Balofloxacin (cas 127294-70-6) ethylene isatin derivatives)